| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/16/2011 | EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2282725A1 Nasal formulations of insulin |
| 02/16/2011 | EP1896481B1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | CN101972449A Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof |
| 02/16/2011 | CN101972430A Traditional Chinese medicament composition for treating dreamed coitus of woman and preparation method thereof |
| 02/16/2011 | CN101972400A Application of sealwort extract to preparing medicament for treating women climacteric metancholia caused by in vivo female hormore hyposecretion |
| 02/16/2011 | CN101972319A Medicinal composition for treating hypertension insulin resistance and preparation method thereof |
| 02/16/2011 | CN101972315A Traditional Chinese medicinal composition and preparation method and use thereof |
| 02/16/2011 | CN101972245A Composition capable of promoting insulin secretion and inhibiting generation of advanced glycosylation end products |
| 02/16/2011 | CN101596223B Method for enriching ginkgetin compound |
| 02/16/2011 | CN101288660B Levonorgestrel drop pills preparation method |
| 02/15/2011 | US7888056 Method of forming a peptide-receptor complex with zsig33 |
| 02/15/2011 | US7887841 Multilayer, drug core, delay release gum compression coatings |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2480872C Amino acids with affinity for the .alpha.-2-.delta.-protein |
| 02/15/2011 | CA2480562C 5-substituted 1,1-dioxo-1,2,5-thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 02/15/2011 | CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/15/2011 | CA2451043C Enhanced drug delivery in transdermal systems |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/10/2011 | WO2011016459A1 Thienooxazepine derivative |
| 02/10/2011 | WO2011015984A1 Orally administerable pharmaceutical preparation containing insulin |
| 02/10/2011 | WO2011015649A1 Growth hormones with prolonged in-vivo efficacy |
| 02/10/2011 | US20110034737 Water-Soluble Polymer Alkanals |
| 02/10/2011 | US20110034518 Pharmaceutical composition |
| 02/10/2011 | US20110034443 Uses of substituted imidazoheterocycles |
| 02/10/2011 | US20110034429 5a-ANDROSTANE-3,6,17-TRIONE (KNELLER'S TRIONE) AND METHODS OF USE THEREFOR |
| 02/10/2011 | US20110034399 Liquid and Freeze Dried Formulations |
| 02/10/2011 | US20110033529 Oral pharmaceutical paricalcitol formulations |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | CA2805958A1 Greater utility with thyroid hormone |
| 02/10/2011 | CA2769620A1 Orally administerable pharmaceutical preparation containing insulin |
| 02/09/2011 | EP2281874A1 Production of ß-Cells |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | EP2281553A2 Pharmaceutical composition and method for treating hypogonadism |
| 02/09/2011 | EP2280994A1 Restoration of estrogen receptor-alpha activity |
| 02/09/2011 | EP2280954A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 02/09/2011 | EP1644321B1 New benzamides as ppaty modulators |
| 02/09/2011 | CN101970452A C20-c21 substituted glucocorticoid receptor agonists |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101966206A Extraction separation method of female hormone active components from tamariskoid spikemoss herb |
| 02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
| 02/09/2011 | CN101647773B Octreotide acetate injection |
| 02/09/2011 | CN101128476B 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2409854C Sustained release pharmaceutical compositions for the parenteral administration of biologically active hydrophilic compounds |
| 02/08/2011 | CA2370466C Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 02/03/2011 | WO2011014707A2 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | WO2011013644A1 Substituted piperidine compound |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011013106A1 Lactic acid bacteria and bifidobacteria for treating endotoxemia |
| 02/03/2011 | WO2011012883A1 Benzo [e] [1, 3 ] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors |
| 02/03/2011 | WO2011012707A1 PRODUCTION OF β-CELLS |
| 02/03/2011 | WO2011011965A1 Luteinising hormone releasing hormone antagonist with hydantoin structure |
| 02/03/2011 | WO2009158412A8 Sustained delivery of exenatide and other polypeptides |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110028501 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/03/2011 | US20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS |
| 02/03/2011 | US20110028394 Therapeutic agents for reducing parathyroid hormone levels |
| 02/03/2011 | CA2769525A1 Therapeutic agents for reducing parathyroid hormone levels |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN101961461A Novel Chinese medicinal material with various effects |
| 02/02/2011 | CN101961329A Application of Silibinin in preparing anti-male hormone medicaments |
| 02/02/2011 | CN101961327A Application of toremifene for preparing medicine of treating androgen-deprivation induced mammogenesis in a male subject |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 01/27/2011 | WO2011011508A1 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/27/2011 | WO2011010080A1 Inhibitor of inflammatory conditions |
| 01/27/2011 | WO2010143803A3 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same |
| 01/27/2011 | WO2009085880A8 C-21 thioethers as glucocorticoid receptor agonists |
| 01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021355 Formulation with reduced hygroscopicity |
| 01/27/2011 | US20110020345 Drug fusions and conjugates |
| 01/27/2011 | CA2768577A1 Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors |
| 01/27/2011 | CA2768448A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 01/27/2011 | CA2768407A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 01/26/2011 | EP2277900A1 Metastin derivative and use thereof |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277520A2 A pharmaceutical composition for angiotensin ii-mediated diseases |
| 01/26/2011 | EP2276732A1 Novel estrogen receptor ligands |
| 01/26/2011 | EP1849795B1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN101955527A Novel insulin derivatives |
| 01/26/2011 | CN101953820A Application of styrene phenol compounds to preparing insulin sensitizer |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |